Who knew there could be
a mom-and-pop pharma company
in the 21st century?
Learn more about our newest
prostate cancer diagnostic imaging drug
Prostate cancer is the second most common cancer in the United States, after skin cancer.
It is the third most lethal.
Let's talk about how we can change the tables,
one person at a time.
Sign up to hear from us. We will send you our most important updates and promise not to spam your inbox.